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Marketing of Second Generation Genetically
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Abstract
The paper examines how the market/consumer acceptance of a second generation,
consumer oriented, genetically modified product (new GMP) affects a company’s market-
ing strategy and its decision to invest in the research and development (R&D) of the new
product. Two relationships between the products available in the market and their effect
on the monopolist’s marketing strategy are considered, namely, vertical and horizontal
product differentiation. Analytical results show that when the new GMP in a vertically
differentiated market is viewed as the low quality product it has to be priced lower than
the conventional product to capture a positive market share while when it is viewed as the
high quality product, it may be able to capture the entire market. Results also show that
the innovating firm may have to price the new GMP lower in the horizontally differentiated
than in the vertically differentiated market in order to enhance its market share.
KEYWORDS: second generation genetically modified product, vertical product differ-
entiation, horizontal product differentiation, consumer heterogeneity
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1. Introduction 
 
In recent years biotechnology has become an important part of the agricultural 
production sector. As first generation, producer oriented, genetically modified 
products (GMPs) (e.g., products that aided production and generally increased 
crop yields) were opposed by the general public in many countries, biotechnology 
companies are now working on developing second generation genetically modi-
fied products which are aimed at the final consumer rather than the producers 
(Lusk 2003).  
Second generation GM products generally have traits that are desirable to 
consumers, such as added nutritional value (e.g., vitamin A enriched rice known 
as Golden Rice) and are aimed at reducing consumer opposition to genetically 
modified foods. Although few are currently on the market, those being marketed 
or developed include high oleic soybeans; sunflower seeds; canola; high lysine 
corn; and high protein wheat. A change in public opinion about genetic modifica-
tion is also being attempted through the development of second generation GMPs 
that have characteristics beneficial for residents of developing countries, where 
the health needs for certain characteristics are large. Examples include the afore-
mentioned vitamin A enriched rice as well as vitamin A enriched maize; the first 
is targeted at Asian and the second at African and South American countries.   
The commercialization of second generation GM products will depend largely 
on perceived consumer value of the additional attributes, the level of consumer 
aversion to GMPs and relative prices of conventional and GM varieties (Gianna-
kas and Yiannaka 2003). If consumers see the end-use benefits, such as health 
benefits, of such products as being large, their acceptance of the product will in-
crease and they will likely pay a premium for the good. On the other hand, if there 
is no perceived end-use benefit, or if little value is placed on the additional attrib-
ute, consumers are less likely to accept the GMP and will do so only at a price 
lower than that of the conventional product (Lusk 2003).    
The level of aversion to genetically modified products differs amongst con-
sumers, and often, this seems largely dependant on their nation of residence. In 
addition, the need within the country for the functional characteristic provided by 
the new GMPs will also affect their consumption, as it will change the value 
placed on the characteristic by consumers. For instance, if a large portion of the 
population is deficient in vitamin A, a product such as Golden Rice will have a 
high value placed on the vitamin A characteristic that is present in Golden Rice 
and not in the conventional product. If the population is not deficient in vitamin 
A, very little value may be placed on receiving the additional vitamin A through 
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the consumption of Golden Rice. Thus, the market demand for vitamin A en-
riched rice in a country such as the Philippines, where a large portion of the 
population is deficient in vitamin A, will be quite different than the demand for 
the same product in the United States where vitamin A deficiency is not a wide-
spread problem. Note however, that even though the value placed on the addi-
tional attribute will be much higher in the Philippines than in the United States the 
price premium that the consumer in the Philippines would be willing and able to 
pay to consume the new GMP will likely be low given the large portion of the 
budget that is spent on food in that country.  
In this context, if Golden Rice were offered in the Philippines at the same 
price as the conventional product, and if the products are viewed as being other-
wise the same (e.g., in taste and appearance) it can be assumed that the products 
would be vertically differentiated, with all consumers ranking the Golden Rice 
higher than the conventional product. If the same product were offered in the 
United States at the same price as the conventional product, it is likely that the 
products would be viewed as being horizontally differentiated by consumers (i.e., 
consumers would not uniformly rank the two products) and both would be present 
in the market. Therefore, a product that captures the whole market in one country 
may not be consumed in another. Thus, the target market/country will affect the 
firm’s marketing strategy. 
The goal of this project is to determine how the market/consumer acceptance 
of a second generation, consumer oriented, genetically modified product (new 
GMP) will affect a company’s marketing strategy and its decision to invest in the 
research and development (R&D) of the new product. Specifically, the paper 
examines the effect of consumer perceptions about the relationship between a new 
GMP and its conventional counterpart (i.e., vertically or horizontally differ-
entiated) on the price that can be charged for the new GMP and the quality level 
of the additional attribute that will be developed by the biotech company intro-
ducing the product in the market.  
 
2. The Analytical Model 
 
A theoretical model is used to analytically examine the above issues. This model 
assumes heterogeneous consumers who have different willingness to pay for the 
products available and a monopolist who develops and introduces to the market a 
new GMP. The market that we are examining consists of two products: a new 
generation genetically modified product and a conventional product that is sup-
plied in a competitive market. It is assumed that each consumer consumes one 
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unit of either the new GMP or the conventional product and that this purchase 
represents a small portion of the individual’s budget. 
Following Giannakas and Yiannaka (2003), it is assumed that consumers are 
heterogeneous and differ in their aversion to the process of genetic modification. 
The differentiating consumer attribute, denoted by α , takes values between zero 
and one and consumers are assumed to be uniformly distributed between these 
values. Thus, a consumer with an α  value equal to zero has no aversion to the 
process of genetic modification, and therefore, is indifferent between the two 
products when those are offered at the same price. The consumer with an α  value 
equal to one is the most averse to genetic modification.     
The expectations about the market share that could be captured by the new 
GMP will affect whether or not the company chooses to conduct research and de-
velopment on the product. The market shares of the products in this market de-
pend in turn on the way consumers view these products. The mass of consumers 
is set at unity so finding the consumer who is indifferent between the two prod-
ucts offered in the market, denoted by αˆ , will determine the market shares of 
both the new GMP and the conventional product. The demand for each product 
can then be determined from the market shares.  
 
 The Market Conditions 
We examine two possible relationships between the products and their effect on 
the monopolist’s marketing strategy: the case where the products are vertically 
differentiated and the case where the products are horizontally differentiated. The 
products are vertically differentiated when consumers can uniformly quality rank 
them; that is, if the two products are offered at the same price, all consumers will 
purchase only one of the products (high quality) and the other product (low qual-
ity) will not be consumed at all. The products are horizontally differentiated 
when, if offered at the same price, both products have a positive market share. A 
modification of the heterogeneous consumer model developed by Giannakas and 
Yiannaka (2003) that accounts for both vertical and horizontal differentiation is 
used in our analysis. 
The utility received from consuming a new GMP and a conventional product 
is given in equation (1): 
(1) γα −−+= NgmNgm PVUU   if a unit of the new GMP is consumed 
 δα+−= cc PUU  if a unit of the conventional product is consumed 
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where U is a base level of utility received by consumers, V is the value consumers 
place on the new product attribute (e.g., vitamin A in GoldenRice) which reflects 
the quality of the product as it is viewed by consumers, NgmP  and cP  are the 
equilibrium prices of the new GMP and the conventional product, respectively, γ  
is a non-negative utility discount factor associated with the consumption of the 
GM product and δ  is a non-negative utility enhancement factor associated with 
the consumption of the conventional product. Thus, consumers in our model ine-
lastically consume one unit of either the new GMP or the conventional product.    
The indifferent consumer derives the same level of utility from the con-
sumption of both products. Therefore, by finding the indifferent consumer, it is 
possible to determine the market shares that will be captured by each product. 
This indifferent consumer is found by setting the above equations equal to each 
other and solving forα . Solving this, the indifferent consumer is found to be lo-
cated at (i.e., has a differentiating attribute equal to) δγα +
+−
 =
∧ c
N
gm PPV . Consum-
ers located to the left of αˆ  will consume the new GMP while consumers located 
to the right of αˆ  will consume the conventional product. Thus, the market share 
of the new-GMP, NgmX , is equal toαˆ , i.e., δγ +
+−
=
c
N
gm PPVN
gmX .  The market share 
of the conventional product, cX , is equal to ˆ1 α− , i.e., 
δγ
δγ
α
+
+−−+
=−=
)(
ˆ1Xc
c
N
gm PPV .  Solving the equation 
δγ +
+−
=
c
N
gm PPVN
gmX  
for the price of the new GM product gives the inverse demand for the new GM 
product, )+−+= δγ(NgmcNgm XPVP , while solving the equation 
δγ
δγ
α
+
+−−+
=−=
)(
ˆ1Xc
c
N
gm PPV  for the price of the conventional product re-
sults in the inverse demand for the conventional product, 
)( δγδγ +−+−+ = cNgmc XPVP . Note that when NgmP  falls below the critical 
value cV P γ δ+ − −  the new GMP captures the entire market (i.e., 1NgmX = ); when 
cP  is lower than 
N
gmP V−  the new GMP makes zero sales (i.e., 0
N
gmX =  and 
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1cX = ). Representations of the inverse demands for the GM and the conventional 
products are given in Figure 1.  
Therefore, the market shares of (and the demands for) the two products are 
determined by the value that consumers place on the additional characteristic in 
the new-GMP, V, the prices of both the new-GMP and the conventional product, 
the level of aversion to the process of genetic modification,γ , and the level of 
utility enhancement received from consuming the conventional product, δ .   
 
CP
δγ +
1
CX0 
cP V γ δ+ − −
δγ +
10 
Panel (i): 
(N Ngm c gmP V P X γ δ= + − + )  
cP V+
N
gmP
N
gmX
Figure 1. Inverse Demands for the New GMP and the Conventional Product 
N
gmP V−
Panel (ii): 
)( δγδγ +−+−+= N XPVP
γ ++−VPNgm
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Vertical Product Differentiation  
  
When the price of the new GMP is equal to the price of the conventional product 
( c
N
gm PP = ), and the value consumers place on the additional characteristic of the 
new GMP is either 0V =  (Case I) or 0V γ δ= + >  (Case II), then the products 
are vertically differentiated as when sold at the same prices only one product will 
have a positive market share. Under Case I where 0V = and the two products are 
offered in the market at the same price, 0ˆ == NgmXα , and the conventional prod-
uct captures the entire market. Thus, in this case the new GMP is viewed as the 
low quality product by all consumers. Under Case II where 0V γ δ= + >  and the 
two products are offered in the market at the same price, 1ˆ == NgmXα  and the 
new GMP captures the entire market. Thus, in this case, the new GMP is viewed 
as the high quality product by all consumers. Given the above, for both products 
to be able to capture a positive market share under vertical differentiation the fol-
lowing conditions must hold: c
N
gm PP <  under Case I (where the new GMP is per-
ceived to be inferior to the conventional product) and c
N
gm PP >  under Case II 
(where the new GMP is perceived as superior to the conventional product). Given 
the above, the greater is the value consumers place on the new GMP’s additional 
attribute, the higher is the price that can be charged by the monopolist. Likewise, 
the lower is consumer aversion to genetic modification, the more likely it is that 
the new GMP will be viewed as the high quality product in this market, ceteris 
paribus.  
A representation of the vertically differentiated market under Cases I and II 
and under Case III where product prices are such that both products capture a 
positive market share are illustrated in panels (i), (ii) and (iii) of Figure 2, respec-
tively. Aggregate consumer welfare in this market is given by the area under the 
utility curve cU  in panel (i) Figure 2, the utility curve 
N
gmU  in panel (ii) Figure 2 
and the kinked dashed line in panel (iii) Figure 2.   
6 RURALS: Review of Undergraduate Research in Agricultural and Life SciencesVol. 1 [2006], No. 1, Article 5
http://digitalcommons.unl.edu/rurals/vol1/iss1/5 8
RURALS: Review of Undergraduate Research in Agricultural and Life Sciences, Vol. 2 [2007], Iss. 1, Art. 4
https://digitalcommons.unl.edu/rurals/vol2/iss1/4
   
 
cPU −
cU
cU
cU
N
gmU
N
gmU
N
gmU
cU P−
 
N
gmPVU −+
 N
gmPVU −+
cPU −
10 
1010 
αˆ
 N
gPVU −+
Figure 2. Market Effects under Vertical Product Differentiation 
Panel (i). Case I:  The market is 
captured by the conventional 
product ( 0=V  and Ngmc PP = ) 
Panel (ii). Case II:  The market is 
captured by the new GM product 
( 0V γ δ= + >  and Ngmc PP = ) 
Panel (iii). Case III: Both products capture a 
portion of the market (( 0=V  and Nc gmP P> ) 
or ( 0V γ δ= + >  and Nc gmP P< ) 
Consumer Utility 
Consumer Utility Consumer Utility 
a a
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Horizontal Product Differentiation  
 
When the price of the new GM product is equal to the price of the conventional 
product ( c
N
gm PP = ) and the value consumers place on the additional characteristic, 
V, is such that 0 V γ δ< < + , then the products are horizontally differentiated as at 
the same prices each product will have a positive market share. A representation 
of this market can be seen in Figure 3. Aggregate consumer welfare is the area 
under the bold curve. In this case, the indifferent consumer,αˆ , falls between zero 
and one, resulting in a horizontally differentiated market.   
In this market setting, when the value placed on the additional characteristic 
of the new GM product by consumers is substantially greater than the difference 
in prices of the new GM and conventional products (i.e., when 
N
gm cV P P γ δ≥ − + + ) only the new GM product will be consumed and the conven-
tional product will be driven out of the market. Note that, when products are hori-
zontally differentiated the value that consumers place on the additional attrib-
ute,V , must be higher than under vertical differentiation for the new GMP to cap-
ture the entire market.  
 
 
cPU −
cU
N
gmU
 PVU −+
δ
αˆ
γ
0 1
Consumer Utility 
Figure 3. Market Effects under Horizontal Product Differentiation.  
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 The Monopolist’s Profits 
 
Having determined how the value consumers place on the additional attribute of 
the new GMP, the level of aversion to genetic modification, the utility enhance-
ment from the consumption of the new product and the product prices affect the 
perceived relationship between the two products, the monopolist decides on the 
quality level of the new GMP that should be developed and how the new product 
should be priced. In order for the new GM product to enter the market, profits 
have to be greater than or equal to zero ( 0≥π ). The profits for the monopolist 
are given by equation (2):  
(2)   Ngm
N
gm
N
gm FXP − = π  
where NgmF  are the R&D costs that need to be incurred in order to produce the new 
GMP.1 Note that these costs are sunk, since once incurred, they cannot be recov-
ered. Since what differentiates the new GMP from ‘traditional’ (first generation) 
GMPs is the additional attribute that appeals to consumers, we assume that the 
R&D costs are an increasing function of the additional attribute V of the form, 
2
2VF Ngm = , with 0>∂
∂
V
F Ngm and 02
2
>
∂
∂
V
F Ngm . Thus, it is assumed that the quality of 
the new GMP (which is endogenous to the monopolist) is directly related and per-
fectly correlated to the value consumers place on the additional attribute. In other 
words, the greater is the effort the monopolist exerts in developing the new prod-
uct attribute, the higher is the value that consumers place on this attribute.2 
 It is further assumed that, once the R&D costs for the development of the new 
GMP have been incurred and the product has been developed, it is costless to 
reproduce; that is, the marginal costs of producing the new GMP are zero. Thus, 
the burden of developing the new GMP falls on fixed rather than variable costs 
                                                 
1 Since this is a static model, the requirement that the profits in equation (2) are greater than or 
equal to zero is a sufficient condition for the development of the new GMP. 
2 This assumption is made to simplify our analysis. We could have assumed that the quality of the 
new GMP, Ngmq , is related to the value consumers place on the product in the following way, 
N
gmV qϑ=  where [0,1]ϑ ∈ . The assumption we make here is equivalent to assuming that 1ϑ = . 
This assumption does not change the qualitative nature of the results.  
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(see Beath and Katsoulacos (1991) for a discussion of the cost of new product 
development).   
Substituting for NgmX  and 
N
gmF  in equation (2) we get: 
(3)  
2
)(
2VPPVP c
N
gmN
gm −+
+−
= δγπ  
Equation (3) indicates that the profits that can be captured by the monopolist de-
pend on the prices of the conventional and genetically modified products, the 
quality of the product captured in the value consumers place on the additional at-
tribute, V, the utility enhancement from the consumption of the conventional 
product,δ , and the utility discount from the consumption of the genetically modi-
fied product,γ .  
The objective of the monopolist is to choose the price, NgmP  and the quality 
of the product reflected in the additional attribute, V, that maximize the profits in 
equation (3), i.e.,  
 (4) 
2
,
max
2Ngm
N
gm cN
gm
P V
V P P VPπ γ δ
⎛ ⎞− +
= −⎜ ⎟⎜ ⎟+⎝ ⎠
 
Optimization of the objective function in equation (4) with respect to NgmP  and V  
yields the following first order conditions (F.O.C.) for a maximum: 
*0
2
N c
gmN
gm
V PP
P
π +∂
= ⇒ =
∂
 
(5) *0
N
gmPV
V
π
γ δ
∂
= ⇒ =
∂ +
 
Simultaneously solving the equations in (5) yields the optimal price for the new 
GMP and the optimal value for the additional attribute given by: 
(6) * ( )
2( ) 1
N c
gm
PP γ δ
γ δ
+
=
+ −
 and *
2( ) 1
cPV
γ δ= + − .  
Equation (6) indicates that the optimal price of the new GMP is proportional to 
the price of the conventional product. As expected, the higher the price of the 
conventional product, the higher is the price of the new GMP that maximizes the 
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monopolist’s profits. In addition, the greater is the consumer aversion to GMPs, 
the smaller is the monopolist’s incentive to invest in the development of the new 
GMP and the smaller is the profit maximizing value of V . In contrast, the greater 
is the price of the conventional product, the easier it is for the new GMP to com-
pete with the conventional product and the greater is the monopolist’s incentive to 
invest in the additional attribute, V . 
Substituting the optimal values for NgmP  and V  into the profit function (equa-
tion 3) gives the maximum level of profits that can be captured by the monopolist 
when he introduces the new GMP in the market. This substitution results in the 
optimal profit function:  
(7) 
2
*
4 4 2
cPπ
γ δ= + −  
Thus, the optimal level of profits that can be captured by the introduction of the 
new GMP are increasing in the price of the conventional product and are de-
creasing in the level of aversion to GMPs,γ , and the utility enhancement from 
consuming the traditional product, δ  (i.e., 
2* *
2
4 0
(4 4 2)
cPπ π
γ δ γ δ
∂ ∂
= = − <
∂ ∂ + −
 
, 0γ δ∀ ≥ ).  
Consumer perceptions about the products available in the market are im-
portant in determining whether or not companies will develop a new-GM product. 
Companies must garner information on the value consumers will place on the ad-
ditional attribute of their product, as well as on the consumer aversion to the proc-
ess of genetic modification. This will allow the company to determine whether 
they will be able to recover their costs and make a profit. If the price would have 
to be quite low in order for the product to be consumed (as in Case I under verti-
cal differentiation where the new GMP is perceived by consumers as being the 
low quality product), the company may not be able to cover costs, and may, there-
fore, not invest in the research and development required to produce the product.   
 
3. Results and Discussion 
 
This paper examines the effect of consumer perceptions about a consumer ori-
ented genetically modified product and its conventional counterpart on the de-
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mand for the new GMP and a firm’s decision to invest in its development and 
commercialization.  
The demand for the new GMP is largely dependant on the country in which 
the product is being marketed as aversion to genetic modification amongst 
consumers differs across countries and the need for the additional attribute present 
in the new GMP may vary between countries. A company’s decision to develop 
and market a product depends on the value consumers place on the additional at-
tribute, the consumer aversion to the process of genetic modification, the utility 
enhancement received from consuming the conventional rather than the new GM 
product and the prices of the products in the market.  
The decisions and marketing strategies of the innovating firm are also affected 
by the nature of differentiation of the new GMPs and their conventional 
counterparts. In particular, our study shows that when a new GMP in a vertically 
differentiated market is viewed as the low quality product it has to be priced lower 
than the conventional product to capture a positive market share. This limitation 
in the pricing strategy of the firm can jeopardize its ability to recoup its R&D 
costs and result in the lack of incentives for the development of the new GMP. If 
the new GMP is viewed as the high quality product in a vertically differentiated 
market, the new GMP may be able to capture the entire market unless the con-
ventional product is priced low enough. 
Our results also show that it is harder for the new GMP to capture the entire 
market under horizontal product differentiation than under vertical product 
differentiation where the new GMP is viewed as the high quality product, i.e., the 
value that consumers place on the additional attribute,V , must be higher under 
horizontal than under vertical differentiation for the new GMP to capture the en-
tire market ( Ngm cV P P γ δ≥ − + +  versus 0V γ δ= + > , respectively). This implies 
that in a horizontally differentiated market, the company producing the new GMP 
will attempt to create the highest value for the additional attribute possible in or-
der to capture as much of the market as possible. 
Finally, our analysis shows that the innovating firm may have to price the new 
GMP lower in the horizontally differentiated than in the vertically differentiated 
market in order to enhance its market share. Given the above, the firm developing 
the new GMP will likely prefer to compete in a vertically differentiated market 
where its product is viewed by consumers as the high quality product.   
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